Your browser doesn't support javascript.
loading
Nuclear Export Inhibition for Radiosensitization: A Proof-of-Concept Phase 1 Clinical Trial of Selinexor (KPT-330) Combined With Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Lawrence, Yaacov R; Shacham-Shmueli, Einat; Yarom, Nirit; Khaikin, Marat; Venturero, Moris; Apter, Sara; Inbar, Yael; Symon, Zvi; Aderka, Dan; Halpern, Naama; Berger, Raanan; Boursi, Ben; Jacobson, Galia; Raskin, Stephen; Ackerstein, Aliza; Margalit, Ofer; Appel, Sarit; Schvimer, Michael; Crochiere, Marsha; Yang, Fan; Landesman, Yosef; Rashal, Tami; Shacham, Sharon; Golan, Talia.
Afiliación
  • Lawrence YR; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel; Department Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: yaacov.lawrence@sheba.health.gov.il.
  • Shacham-Shmueli E; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Yarom N; Shamir Medical Center affiliated with Tel Aviv University, Be'er Yaakov, Israel.
  • Khaikin M; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Venturero M; Laniado Hospital, Netanya, Israel.
  • Apter S; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Inbar Y; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Symon Z; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Aderka D; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Halpern N; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Berger R; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Boursi B; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Jacobson G; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Raskin S; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Ackerstein A; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Margalit O; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Appel S; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Schvimer M; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
  • Crochiere M; Karyopharm Therapeutics, Newton, Massachusetts.
  • Yang F; Karyopharm Therapeutics, Newton, Massachusetts.
  • Landesman Y; Karyopharm Therapeutics, Newton, Massachusetts.
  • Rashal T; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel; Merlin Health, Boston, Massachusetts.
  • Shacham S; Karyopharm Therapeutics, Newton, Massachusetts.
  • Golan T; Sheba Medical Center affiliated with Tel Aviv University, Ramat Gan, Israel.
Int J Radiat Oncol Biol Phys ; 114(2): 250-255, 2022 10 01.
Article en En | MEDLINE | ID: mdl-35667526
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Terapia Neoadyuvante Límite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Terapia Neoadyuvante Límite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2022 Tipo del documento: Article